GSK (GSK, $42.99) was one of top quarterly gainers, jumping +1 to $42.99 per share. A.I.dvisor analyzed 56 stocks in the Pharmaceuticals: Major Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.